Diagnostic Challenges and Key insights of Nitrous Oxide Neuropathy: A Case series
DOI:
https://doi.org/10.17161/rrnmf.v6i2_2025.23764Keywords:
Neuropathy, Nitrous Oxide, Vitamin B12, ToxicAbstract
Nitrous oxide (N₂O) is increasingly misused due to its easy availability. Chronic misuse causes irreversible oxidation of cobalamin which results in vitamin B12 deficiency and impaired myelination leading to neurological complications. We present two cases highlighting diagnostic challenges consisting of a 34-year-old male and a 52-year-old, both initially misdiagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP). They were eventually diagnosed as N₂O-induced neuropathy based on lab testing and electrodiagnostic findings. Clinicians should maintain a high suspicion of N₂O misuse in unclear neuropathies. Early recognition with prompt and sustained vitamin B12 supplementation is crucial for preventing irreversible neurological damage and avoiding unnecessary immunotherapy.
Downloads
References
1. Kaar SJ, Ferris J, Waldron J, Devaney M, Ramsey J, Winstock AR. Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. Journal of psychopharmacology. 2016 Apr;30(4):395-401.
2. Zou X, Yi F, Zhou W, Dong Y, Alhaskawi A, Zhou H, Ezzi SH, Kota VG, Abdulla MH, Alenikova O, Abdalbary SA. Mechanisms and recent advances in the diagnosis and treatment of nitrous oxide-induced peripheral neuropathy: a narrative review. Frontiers in Neurology. 2024 May 23;15:1381938 (tel:1381938).
3. McCormick B, Thomas J, Patel R, Anderson N. Nitrous oxide-induced myeloneuropathy: an emerging public health issue. Neurology. 2023;101(14):e1567–75.
4. Singer MA, Lazaridis C, Nations SP, Wolfe GI. Reversible nitrous oxide-induced myeloneuropathy with pernicious anemia: case report and literature review. Muscle Nerve. 2007;36(5):614–6.
5. Berling I, Isbister GK, Grice J, Graudins A. Nitrous oxide-induced predominantly motor neuropathies: a follow-up study. Clin Toxicol (Phila). 2022;60(5):452–8.
6. Darmiga R, Patel N, Youngstein T. Nitrous oxide-induced neurotoxicity: a case report and literature review. BMJ Case Rep. 2021;14(6):e241279.
7. Mair D, Paris A, Zaloum SA, White LM, Dodd KC, Englezou C, Patel F, Abualnaja S, Lilleker JB, Gosal D, Hayton T, Liang D, Allroggen H, Pucci M, Keddie S, Noyce AJ. Nitrous oxide-induced myeloneuropathy: a case series. J Neurol NeurosurgPsychiatry. 2023 Sep;94(9):681-688.
8. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T. The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain. 2005 Nov 1;128(11):2518-34.
9. Mülsch A, Busse R. The potent vasodilating and guanylyl cyclase-activating dinitrosyl-iron(II) complex is stored in a protein-bound form and released by thiols. Eur J Pharmacol. 1991;202(1):97–102.
10. Dong MX, Wang Q, Xu JF, Hu L, Yu Y, Li T. Case report: Recreational nitrous oxide abuse triggered peripheral neuropathy possibly through the immune-mediated pathogenesis. Frontiers in Neurology. 2022 Nov 14;13:1033327 (tel:1033327).
11. Oussalah A, Julien M, Levy J, Hajjar O, Franczak C, Stephan C, Laugel E, Wandzel M, Filhine-Tresarrieu P, Green R, Guéant JL. Global burden related to nitrous oxide exposure in medical and recreational settings: a systematic review and individual patient data meta-analysis. Journal of clinical medicine. 2019 Apr 23;8(4):551.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Govind S. Mann, Mustafa Al-Kharsan , Constantine Farmakidis , Mazen M. Dimachkie , Long Davalos , Mamatha Pasnoor
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
